Pfizer
Company and Pharmaceutical Company
Pfizer gets FDA approval for intravenous RevatioNEW YORK (AP) - Drug developer Pfizer Inc. said Friday the Food and Drug Administration approved an intravenous version of its high blood pressure drug Revatio. The drug was already sold as a tablet. It is used as a treatment for adults... In this article: Pfizer Inc., Revatio, Food and Drug Administration, Hypertension, and NEW YORK |
-
Reuters | 4 days ago
UPDATE 1-Pfizer says may enter Japan generic drug market
...may enter from 2011 * Japan generic drugmaker shares rise, shrug off news (Recasts with confirmation) By Yumiko Nishitani Pfizer Inc <PFE.N>, the world's largest drugmaker, said on Thursday it may start selling generic drugs in Japan...
In this article: Japan, Europe, Business operations, Wyeth, North America, and Asia
-
AP Online | 4 days ago
FDA panel backs Pfizer's enhanced vaccine for kids
BETHESDA, Md. (AP) - Federal health experts said Wednesday an updated version of Pfizer's best-selling anti-infection vaccine is safe and effective for infants and toddlers, despite company studies that failed to meet certain goals. The...
In this article: Food and Drug Administration, Wyeth, GlaxoSmithKline, Merck, Meningitis, European Union, and U.S.
-
UPDATE 1-US panel backs Pfizer's newer Prevnar vaccine
* FDA panel: Pfizer's Prevnar 13 safe, effective * Pfizer shares up 1.3 pct Pfizer Inc's <PFE.N> newer version of the Prevnar pneumococcus vaccine, the most important experimental product the company acquired from Wyeth, won support...
In this article: Food and Drug Administration, US, Streptococcus pneumoniae, Meningitis, Wyeth, and New York Stock Exchange
-
UPDATE 2-US FDA wants panel to probe Pfizer vaccine efficacy
...results * Pfizer says overall data show vaccine effective Recasts; Adds company, analyst comment) By Lisa Richwine Pfizer Inc's <PFE.N> next- generation Prevnar vaccine missed some of the main goals in a study testing its ability to...
In this article: Wyeth, Food and Drug Administration, United States, Europe, Streptococcus pneumoniae, European Medicines Agency, and World Health Organization
-
Conn. residents: Pfizer land battle unnecessary
NEW LONDON, Conn. (AP) - After drug giant Pfizer Inc. announced that it was opening a new research center here, city officials aggressively moved to acquire surrounding land for an economic development project - triggering an epic fight...
In this article: Pfizer Inc., Dana Berliner, U.S. Supreme Court, and Connecticut
-
Pfizer says absorbing Wyeth at top speed
By Ransdell Pierson and Bill Berkrot Pfizer Inc CEO Jeffrey Kindler said the drugmaker is integrating its Wyeth purchase far faster than previous big acquisitions, and it will no longer be overly dependent on one or two blockbuster...
In this article: Wyeth, Lipitor, Revenue, Alzheimer's disease, United States, and Pharmacia
Trends
Loading...
Collections
More on Pfizer
Description from Wikipedia:
Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. It produces Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), antibiotic Zithromax (azithromycin), Viagra (sildenafil citrate), and the anti inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside USA and Canada, mainly in South America).
Pfizer's shares were made a component of the Dow Jones Industrial Average on April 8, 2004.
Pfizer pled guilty in 2009 to the largest health care fraud in U.S. history and received the largest criminal penalty ever levied for illegal marketing of four of its drugs. Called a repeat offender, this is Pfizer's fourth such settlement with the U.S. Department of Justice in the last ten years.
On January 26, 2009, Pfizer agreed to buy pharmaceutical giant Wyeth for US$68 billion, a deal financed with cash, shares and loans.
- Name:
- Pfizer, Inc.
- Type:
- [[Public company
- Location:
- New York City, NY, USA
- Founded:
- Brooklyn, NY, USA (1849)
- Stock Symbol:
- PFE
- Industry:
- Health Care
- Key People:
-
- Martin Mackay, Pres. of R&D
- Amy Schulman, GC
- Jeff Kindler, CEO
- Ian Read, Pres. of Pharma.
- David Shedlarz, VC
- Revenue:
- $48.296 billion USD (2008), 1% from 2007
- Net Income:
- $8.104 billion USD (2008), 1% from 2007
- No. of Employees:
- 86,600 (2008)
- Motto:
- Working for a healthier world
Explore everything named Pfizer...
